Singulair and suicidal tendencies fda report

13 Jan 2009 On March 27, 2008, FDA announced that it was reviewing safety data that raised No patients in the placebo group had suicidal ideation or suicide. The clinical details of some reports involving montelukast are consistent 26 Sep 2013 In April 2009, the Food and Drug Administration (FDA) finished its was a result of reports of people attempting suicide while taking Singulair

27 Mar 2008 The FDA has asked Merck to look at Singulair study data for more information about reports of behavior and mood changes, suicidal thoughts

23 Jun 2013 Leukotriene antagonists include montelukast (Singulair), zafirlukast The FDA is evaluating reports of suicidal tendencies associated with 27 Mar 2008 Possible Link Between Singulair Use and Suicide Risk Isn39t Certain The FDA is reviewing postmarketing reports it has received of 12 May 2008 The FDA is also reviewing its postmarketing reports of clinical trials of Singulair found no reported suicides or suicidal thoughts or behavior

Drug Safety Information for Heathcare Professionals gt Follow-up to

MedWatch The FDA Safety Information and Adverse Event Reporting Program Feeling anxious Suicidal thoughts and actions (including suicide) Page Last 21 Jul 2012 However, side effects like suicidal thoughts and actions, tremors and In March of 2008, the FDA released a safety alert about the use of this The manufacturer of Singulair, Merck amp Co., Inc. has received reports of users

27 Mar 2008 FDA Investigates Possible Suicide Link With Montelukast (Singulair) suicidality (suicidal thoughts and behavior), and suicide, the agency 15 Jan 2009 On Tuesday, the FDA announced that an investigation into Merck39s clinical Reports of suicidal thoughts: 1 (treated with Singulair) Attempted